Lv42
740 积分 2024-04-22 加入
Multicenter comparison of high concentration contrast agent iomeprol-400 with iso-osmolar iodixanol-320: contrast enhancement and heart rate variation in coronary dual-source computed tomographic angiography
21天前
已完结
Safety profile of new non-ionic contrast media: renal tolerance
21天前
已完结
Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention
21天前
已完结
Toremifene: an evaluation of its safety profile
1个月前
已完结
Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials
1个月前
已完结
Effects of toremifene versus tamoxifen on breast cancer patients: a meta-analysis
1个月前
已完结
Toremifene, rather than tamoxifen, might be a better option for the adjuvant endocrine therapy in CYP2D6*10T/T genotype breast cancer patients in China
1个月前
已完结
皖公网安备34019202002308
